Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Share-based Compensation (2020 - 2025)

Caribou Biosciences has reported Share-based Compensation over the past 6 years, most recently at $2.7 million for Q4 2025.

  • Quarterly Share-based Compensation fell 29.99% to $2.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $12.7 million through Dec 2025, down 24.1% year-over-year, with the annual reading at $12.7 million for FY2025, 24.1% down from the prior year.
  • Share-based Compensation was $2.7 million for Q4 2025 at Caribou Biosciences, down from $2.9 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $4.7 million in Q2 2024 and troughed at $343000.0 in Q1 2021.
  • The 5-year median for Share-based Compensation is $3.1 million (2022), against an average of $2.9 million.
  • Year-over-year, Share-based Compensation surged 781.63% in 2022 and then crashed 33.96% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $1.6 million in 2021, then skyrocketed by 96.51% to $3.1 million in 2022, then grew by 14.67% to $3.6 million in 2023, then rose by 9.98% to $3.9 million in 2024, then dropped by 29.99% to $2.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Share-based Compensation are $2.7 million (Q4 2025), $2.9 million (Q3 2025), and $3.1 million (Q2 2025).